As the Alzheimer’s drug landscape shifts, drugmakers are developing the next class of treatments. Host Kelly Hooper talks with Katherine Ellen Foley about the future of such therapies.
As the Alzheimer’s drug landscape shifts, drugmakers are developing the next class of treatments. Host Kelly Hooper talks with Katherine Ellen Foley about the future of such therapies.